Company / Operating Cash Flow
BIOMERICA INC Operating Cash Flow History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$3.8M
FY2024
5-year range
-$5.5M / -$479.0K
FY2020-FY2024
Trend
+28.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 9 years, ranging from -$5M in FY2022 to -$479,000 in FY2021.
Based on SEC 10-K filings.
-$4M in FY2024.
Improved from -$5M to -$4M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating cash flow increased 28.4% year-over-year.
- Peak operating cash flow was recorded in FY2021.
- Lowest operating cash flow in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -$3.8M | +28.4% |
| FY2023 | -$5.4M | +2.1% |
| FY2022 | -$5.5M | -1042.8% |
| FY2021 | -$479.0K | +90.9% |
| FY2020 | -$5.3M | -134.0% |
| FY2019 | -$2.2M | +0.0% |
| FY2018 | -$2.2M | -91.1% |
| FY2017 | -$1.2M | -62.4% |
| FY2016 | -$722.9K | -246.2% |
As of FY2024 · SEC Form 10-K · Last checked Jun 22, 2026